Filing Details
- Accession Number:
- 0001537250-13-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-20 19:42:44
- Reporting Period:
- 2012-03-22
- Filing Date:
- 2013-03-20
- Accepted Time:
- 2013-03-20 19:42:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1159019 | Tribute Pharmaceuticals Canada Inc. | TBUFF | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1537250 | Paul Robert Harris | 5590 Steeles Avenue West Milton A6 L9T 2Y1 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2012-03-22 | 550,000 | $0.56 | 7,700,000 | No | 4 | P | Direct | |
Common Shares | Acquisiton | 2012-03-22 | 550,000 | $0.56 | 8,250,000 | No | 4 | P | Indirect | spousal ownership |
Common Shares | Acquisiton | 2013-02-27 | 625,000 | $0.40 | 8,875,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | spousal ownership |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Share | Warrant A | Acquisiton | 2013-02-27 | 312,500 | $0.50 | 312,500 | $0.50 |
Common Share | Warrant B | Acquisiton | 2013-02-27 | 312,500 | $0.60 | 312,500 | $0.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
312,500 | 2013-02-27 | 2015-02-27 | No | 4 | P | Direct |
625,000 | 2013-02-27 | 2018-02-27 | No | 4 | P | Indirect |